Authors
Latest:
Sartorius In-Line Lysis System: The Easiest Alternative to Batch Alkaline LysisWebinar Date/Time: Tue, Jun 11, 2024 10:00 AM EDT
Latest:
Preventing Microbial Contamination of Viral Vaccines and VectorsThe risks of microbial contamination inherent in the production of viral vaccines and viral vectors used in biotherapeutic applications must be addressed.
Latest:
Preventing Microbial Contamination of Viral Vaccines and VectorsThe risks of microbial contamination inherent in the production of viral vaccines and viral vectors used in biotherapeutic applications must be addressed.
Latest:
Preventing Microbial Contamination of Viral Vaccines and VectorsThe risks of microbial contamination inherent in the production of viral vaccines and viral vectors used in biotherapeutic applications must be addressed.
Latest:
Preventing Microbial Contamination of Viral Vaccines and VectorsThe risks of microbial contamination inherent in the production of viral vaccines and viral vectors used in biotherapeutic applications must be addressed.
Latest:
Viewpoint: The Driver of Drug DeliveryAdvances in medicine and consumer electronics can enhance drug delivery and patient care.
Latest:
Third-Party Audits: Ensuring That Excipients Meet cGMP RequirementsIncreasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials.
Latest:
Third-Party Audits: Ensuring That Excipients Meet cGMP RequirementsIncreasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials.
Latest:
Third-Party Audits: Ensuring That Excipients Meet cGMP RequirementsIncreasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials.
Latest:
Understanding Excipient Characteristics to Ensure Robust Continuous ManufacturingKey information is needed for excipients and their potential impact on continuous manufacturing processes.
Latest:
Planning a Successful MES DeploymentPreventing problems in implementing a manufacturing execution system requires upfront analysis and detailed planning.
Latest:
Hard Capsules as a Flexible Dosage FormInnovations in hard-capsule technology enhance the flexibility that hard capsules can provide for dosage forms.
Latest:
Hard Capsules as a Flexible Dosage FormInnovations in hard-capsule technology enhance the flexibility that hard capsules can provide for dosage forms.
Latest:
Process Development Best Practices for Topical Drug ProductsUsing a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing.
Latest:
Process Development Best Practices for Topical Drug ProductsUsing a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing.
Latest:
Natural Superpowers? Supernatural Wide pH-Range!SCHOTTs latest vial innovation, is the only barrier coating for high pH fillings with hydrophobic surface combining all advantages of the Type I middle borosilicate glass container and the well-known 1-layer PICVD coating of SCHOTT.
Latest:
AAPS Traces the Path to ICH M10Efforts strive to harmonize bioanalytical method validation for non-clinical and clinical studies.
Latest:
Standards-Setting Activities on ImpuritiesUSP's focus in 2013 involves standards relating to organic impurities, measurement of residual DNA and host-cell proteins in biotechnology products, and elemental impurities.
Latest:
Improvement of Structural Profiling of N-glycans in BiologicsA suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.
Latest:
Improvement of Structural Profiling of N-glycans in BiologicsA suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.
Latest:
Improvement of Structural Profiling of N-glycans in BiologicsA suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.
Latest:
Improvement of Structural Profiling of N-glycans in BiologicsA suitable tool for analyzing glycans in biopharmaceutical manufacturing is the growing use of analytical enzymes known as exoglycosidases.
Latest:
Understanding Internal Release LimitsInternal release limits help ensure that a batch of drug product remains within specifications throughout its shelf life. This article explores what internal release limits are and why they are important.
Latest:
Using Nondestructive in-situ Measurements to Ensure Lyophilized Product StabilityNon-destructive surface area measurement can improve stability testing.
Latest:
Understanding Internal Release LimitsInternal release limits help ensure that a batch of drug product remains within specifications throughout its shelf life. This article explores what internal release limits are and why they are important.
Latest:
Understanding Internal Release LimitsInternal release limits help ensure that a batch of drug product remains within specifications throughout its shelf life. This article explores what internal release limits are and why they are important.
Latest:
Understanding Internal Release LimitsInternal release limits help ensure that a batch of drug product remains within specifications throughout its shelf life. This article explores what internal release limits are and why they are important.
